Value of FDG-PET/CT using unfractionated heparin for managing primary cardiac lymphoma and several key findings

Journal of Nuclear Cardiology

Volumn 18, Issue 3, 2011, Pages 516-520

  Minamimoto, Ryogo ^a   Morooka, Miyako ^a   Kubota, Kazuo ^a   Ito, Kimiteru ^b   Masuda Miyata, Yoko ^c   Mitsumoto, Takuya ^a   Hirai, Risen ^d   Okazaki, Osamu ^a   Hiroe, Michiaki ^a  

^a NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

^c Iwai Medical Foundation   (Japan)

^d Division of Hematology   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; HEPARIN; IODOFILTIC ACID I 123; PREDNISONE; RITUXIMAB; VINCRISTINE;

AGED; ANGIOCARDIOGRAPHY; ARTERIAL WALL THICKNESS; ARTICLE; CANCER RADIOTHERAPY; CARDIAC LYMPHOMA; CASE REPORT; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC VALUE; DRUG UPTAKE; FEMALE; FEVER; HEART MUSCLE BIOPSY; HEART MUSCLE ISCHEMIA; HEART SCINTISCANNING; HUMAN; LYMPHOMA; PRIMARY TUMOR; PRIORITY JOURNAL; SWELLING; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; VASCULARIZATION;

AGED; ANTICOAGULANTS; FEMALE; FLUORODEOXYGLUCOSE F18; HEART NEOPLASMS; HEPARIN; HUMANS; LYMPHOMA; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; SUBTRACTION TECHNIQUE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 79960390262     PISSN: 10713581     EISSN: 15326551     Source Type: Journal    
DOI: 10.1007/s12350-011-9358-z     Document Type: Article

References (21)

1. Konety SH, Wooldridge JE, Kerber RE. Primary cardiac non-Hodgkin's lymphoma diagnosed by transthoracic echocardiogra-phy. Echocardiography 2006;23:147-8.
2. Butany J, Nair V, Naseemuddin A, Nair GM, Catton C, Yau T. Cardiac tumours: Diagnosis and management. Lancet Oncol 2005;6:219-28. (Pubitemid 40450713)
3. Petrich A, Cho SI, Billett H. Primary cardiac lymphoma: An analysis of presentation, treatment, and outcome patterns. Cancer 2011;117:581-9.
4. Miguel CE, Bestetti RB. Primary cardiac lymphoma. Int J Cardiol 2010 (online first).
5. Devbhandari MP, Meraj S, Jones MT, Kadir I, Bridgewater B. Primary cardiac sarcoma: Reports of two cases and a review of current literature. J Cardiothorac Surg 2007;2:34.
6. Moore JA, DeRan BP, Minor R, Arthur J, Fraker TD Jr. Trans-esophageal echocardiographic evaluation of intracardiac lymphoma. Am Heart J 1992;124:514-6.
7. Mügge A, Daniel WG, Haverich A, Lichtlen PR. Diagnosis of noninfective cardiac mass lesions by two-dimensional echocardi-ography. Comparison of the transthoracic and transesophageal approaches. Circulation 1991;83:70-8.
8. Araoz PA, Eklund HE, Welch TJ, Breen JF. CT and MR imaging of primary cardiac malignancies. Radiographics 1999;19:1421-34.
9. Ryu SJ, Choi BW, Choe KO. CT and MR findings of primary cardiac lymphoma: Report upon 2 cases and review. Yonsei Med J 2001;42:451-6.
10. Zhang M, Li B, Jiang X. PET/CT imaging in a case of cardiac liposarcoma. J Nucl Cardiol 2008;15:473-5.
11. Kosuda S, Kusano S, Ohsuzu F. Primary myocardial lymphoma demonstrated by Tl-201, Tc-99m sestamibi, and Ga-67 SPECT. Clin Nucl Med 1998;23:482-3. (Pubitemid 28470872)
12. Su HY, Huang HL, Sun CM, Hou SM, Chen ML. Primary cardiac lymphoma evaluated with integration of PET/CT and contrast-enhanced CT. Clin Nucl Med 2009;34:298-301.
13. Cho JM, Sohn IS, Yang YJ. Heart in the heart: Dual faced primary cardiac lymphoma on PET-CT. Int J Cardiol 2010;142:e40-1.
14. Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, et al. Revised response criteria for malignant lym-phoma. J Clin Oncol 2007;25:579-86. (Pubitemid 350002966)
15. Tsukamoto N, Kojima M, Hasegawa M, Oriuchi N, Matsushima T, Yokohama A, et al. The usefulness of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) and a comparison of (18)F-FDG-pet with (67)gallium scintigraphy in the evaluation of lymphoma: Relation to histologic subtypes based on the World Health Organization classification. Cancer 2007;110: 652-9. (Pubitemid 47106156)
16. Hicks RJ, Mac Manus MP, Seymour JF. Initial staging of lym-phoma with positron emission tomography and computed tomography. Semin Nucl Med 2005;35:165-75. (Pubitemid 41149006)
17. Ishimaru S, Tsujino I, Takei T, Tsukamoto E, Sakaue S, Kamigaki M, et al. Focal uptake on 18F-fluoro-2-deoxyglucose positron emission tomography images indicates cardiac involvement of sarcoidosis. Eur Heart J 2005;26:1538-43. (Pubitemid 41373496)
18. Nuutila P, Koivisto VA, Knuuti J, Ruotsalainen U, Teräs M, Haaparanta M, et al. Glucose-free fatty acid cycle operates inhuman heart and skeletal muscle in vivo. J Clin Invest 1992;89:1767-74.
19. Wisneski JA, Gertz EW, Neese RA, Gruenke LD, Morris DL, Craig JC. Metabolic fate of extracted glucose in normal human myocardium. J Clin Invest 1985;76:1819-27. (Pubitemid 16196050)
20. Watanabe R, Tomita N, Takeuchi K, Sakata S, Tateishi U, Tanaka M, et al. SUVmax in FDG-PET at the biopsy site correlates with the proliferation potential of tumor cells in non-Hodgkin lymphoma. Leuk Lymphoma 2010;51:279-83.
21. Mikhaeel NG. Use of FDG-PET to monitor response to chemotherapy and radiotherapy in patients with lymphomas. Eur J Nucl Med Mol Imaging 2006;33:22-6.